---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-22-000092"
form_type: "8-K"
ticker: "AXIM"
cik: "0001514946"
company_name: "AXIM BIOTECHNOLOGIES, INC."
filed_at: "2022-01-12T23:59:59+00:00"
generated_at: "2026-06-27T18:36:58.332312+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AXIM appoints Blake N. Schroeder as director to fill vacancy, effective Jan 6, 2022

## Summary
- Schroeder replaces Mauricio Javier Gatto-Bellora, appointed by written consent of Series C preferred stockholder.
- Schroeder serves as CEO and Chairman of Medical Marijuana, Inc., which holds ~16.4% of AXIM common stock.
- He formerly served as COO of Forevergreen International and held roles at MonaVie; holds a J.D. and B.S. in Finance.
- No related-party transactions or arrangements exist between Schroeder and AXIM.

## SEC filing metadata
- accession: 0001096906-22-000092
- form_type: 8-K
- ticker: AXIM
- cik: 0001514946
- company_name: AXIM BIOTECHNOLOGIES, INC.
- filed_at: 2022-01-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/0001096906-22-000092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/axim-20220106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-22-000092
- JSON: https://secwatch.observer/filing/0001096906-22-000092.json
- Plain text: https://secwatch.observer/filing/0001096906-22-000092.txt

## Key facts
- Executive change
  Mauricio Javier Gatto-Bellora resigned as Director at AXIM BIOTECHNOLOGIES, INC..
  - Action: resigned
  - Role: Director
  source text: consented by written consent in lieu of a meeting appointing Blake N. Schroeder to fill the director seat vacated by the resignation of Mauricio Javier Gatto-Bellora.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/0001096906-22-000092-index.htm
- Executive change
  Blake N. Schroeder was appointed as Director at AXIM BIOTECHNOLOGIES, INC..
  - Action: appointed
  - Role: Director
  source text: consented by written consent in lieu of a meeting appointing Blake N. Schroeder to fill the director seat vacated by the resignation of Mauricio Javier Gatto-Bellora.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/0001096906-22-000092-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.